ResMed is a global medical equipment company specializing in the development, manufacturing, and distribution of products and solutions for the treatment of sleep-related breathing disorders and other respiratory conditions. The company was founded in 1989 by Dr. Peter Farrell in Sydney, Australia. Initially, ResMed focused on developing devices to treat obstructive sleep apnea (OSA) and later expanded its portfolio to address various respiratory conditions.
ResMed's core products include continuous positive airway pressure (CPAP) machines, masks, and other respiratory devices that help patients breathe more comfortably and improve their quality of sleep. These devices are used in the treatment of sleep apnea and other chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma.
Headquartered in San Diego, California, ResMed operates on a global scale, with a presence in over 140 countries. The company has established manufacturing facilities and distribution centers in various regions to serve its international customer base effectively. ResMed is a publicly traded company listed on both the New York Stock Exchange (NYSE) under the ticker symbol "RMD" and the Australian Securities Exchange (ASX) under the ticker symbol "RMD."
In addition to its hardware products, ResMed also offers software solutions that facilitate remote patient monitoring, data management, and treatment adherence tracking. The company's cloud-based platform, AirView, enables healthcare providers to monitor and adjust their patients' therapy remotely, promoting better patient outcomes and greater efficiency in healthcare delivery.